-
Abstract Number: PB2287
D-dimer Diagnostics: An International Assessment of the Quality of Laboratory Testing
-
Abstract Number: PB2261
D-Dimer is Useful in the Assessment of Suspected Recurrent Venous Thromboembolism in Patients on Rivaroxaban or Apixaban
-
Abstract Number: PB2277
D-Dimer Plasma Levels and the Anatomical Extension of Acute Symptomatic Deep Vein Thrombosis of the Lower Limbs
-
Abstract Number: PB2516
D-Dimer Variability in the Postpartum Period
-
Abstract Number: PB0993
Data Mining: An Innovative Approach to Optimise Post-Hoc Analyses of Large Trial Data Sets into Clinically Relevant Results
-
Abstract Number: OC 03.3
Deciphering the Ets-1/2-mediated Transcriptional Regulation of F8 Gene Identifies a Minimal F8 Promoter for Hemophilia A Gene Therapy
-
Abstract Number: PB0487
Deciphering the Protein Secretome of Leukocyte-platelet Rich Fibrin
-
Abstract Number: PB2199
Decreased Expression of Annexin A2 Is Associated with Reduced Cell Surface Fibrinolysis and Venous Thromboembolism
-
Abstract Number: PB0846
Decreased Platelet Surface Phosphatidylserine Predicts Increased Bleeding in Patients with Severe Factor VIII Deficiency
-
Abstract Number: PB2147
Decreased Thrombin Generation Potential in Lymphoma Patients Is Associated with Increased D-dimer, CRP, vWF and TNF-α. Interrelationship between Thrombogenesis and Inflammation
-
Abstract Number: PB0748
Deep Mutational Scanning and High-Throughput Kinetics to Quantitatively Assess Plasminogen Activator Inhibitor-1 Variants
-
Abstract Number: PB0215
Deep Vein Thrombosis and Coagulation Factor Deficiency: A Paradoxical Association
-
Abstract Number: PB2238
Deep Vein Thrombosis Associated with Protein S Deficiency
-
Abstract Number: PB2144
Deep Venous Thrombosis and Intraductal Papillary and Mucinous Tumor of the Pancreas: about 3 Cases
-
Abstract Number: PB2304
Deep Venous Thrombosis with Atypical Location: About 22 Cases
-
Abstract Number: PB1488
Defective Endocytosis of Albumin, Fibrinogen and IgG in Platelets with RUNX1 Haplodeficiency
-
Abstract Number: PB1502
Defective RAB31-mediated Endosomal Trafficking in RUNX1 Haplodeficiency
-
Abstract Number: PB1996
Defibrotide Prevents Sepsis Induced Endothelial Cell Activation
-
Abstract Number: PB0473
Defining Acetylsalicylic Acid Responsiveness: Understanding the Relation between Thromboxane B2 Inhibition and Aggregation Induced by Arachidonic Acid
-
Abstract Number: PB1848
Defining the Effects of Storage Lesion on Platelet Autophagic Activity
-
Abstract Number: PB1582
Degradation of High Molecular Weight von Willebrand Factor Multimers during Extracorporeal Membrane Oxygenation-Treatment
-
Abstract Number: PB0278
Delay in Time to Hip Fracture Repair Surgery among Elderly Patients Treated with Anti Platelet Therapy
-
Abstract Number: PB2402
Demographics and Clinical Outcomes of Older Adults Treated for Acute Venous Thromboembolism
-
Abstract Number: PB2400
Demographics and Clinical Outcomes of Patients Younger than 40 Years Treated for Acute Venous Thromboembolism
-
Abstract Number: PB1992
Design and Characterization of Novel Activated Protein C (APC) Variants for the Proteolysis of Cytotoxic Extracellular Histone H3
-
Abstract Number: PB1157
Design of a Novel Factor IX Albumin Fusion Protein with Enhanced Coagulant Activity and Pharmacokinetic Profile
-
Abstract Number: PB0259
Design of Polyphosphate Inhibitors that Reduce Thrombosis without Increased Bleeding
-
Abstract Number: PB1330
Desmopressin for Procedures or Radiological Interventions (DRIVE): Participant Characteristics in a Placebo-Controlled Double-Blind, Randomised Feasibility Trial of Desmopressin in Thrombocytopenic Critically Ill Patients Prior to Procedures
-
Abstract Number: PB1390
Desmopressin for Reversal of Antiplatelet Drugs in Stroke due to Haemorrhage (DASH): Interim Report on Recruitment from a Phase II Double Blind Randomised Controlled Trial
-
Abstract Number: PB1579
Desmopressin in Patients with Type 2B von Willebrand Disease: Differential Impact on VWF and Platelet Function
-
Abstract Number: PB1133
Desmopressin Response and Clinical Outcome in Bleeding Disorders: A 30 Year Retrospective Analysis
-
Abstract Number: PB0893
Detectability and Clinical Significance of Calcium Exchange and 25 (OH) D in the Development of Osteoporosis in Patients with Hemophilia
-
Abstract Number: PB0246
Detecting Oral Kallikrein-Targeting Therapy through Triggered Contact Activation: A Phase I Study
-
Abstract Number: PB0344
Detection and Quantification of F8 Inv1 and Inv22 Inversions Using Digital Droplet PCR and Mile-post Assays
-
Abstract Number: PB1393
Detection of Clopidogrel Resistance: Comparison of Light Transmission Aggregometry and INNOVANCE® PFA P2Y Cartridge and Correlation with CYP2C19 Variants
-
Abstract Number: PB2292
Detection of MicroRNA-126 as a Plasma Biomarker for Diagnosis of DVT
-
Abstract Number: PB1423
Detection of Pathogenic Anti-platelet Factor 4 Antibodies by Impedance Spectroscopy
-
Abstract Number: PB0829
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations
-
Abstract Number: PB2014
Determinants of Neutrophil Extracellular Trap Formation in the General Population: Based on the Rotterdam Study Cohort
-
Abstract Number: PB0676
Determination of Serotonin Concentration in Single Human Platelets by Single-entity Electrochemistry
-
Abstract Number: PB1445
Determination of the Genotype of von Willebrand Disease Type 3
-
Abstract Number: PB2290
Determining Predictive Factors of Venous Thromboembolism Using Design of Experiments
-
Abstract Number: PB1149
Determining the Approximate Factor VIII Level Equivalency of Patients with Severe Hemophilia A on Emicizumab Using Global Hemostasis Assays
-
Abstract Number: PB1152
Determining the Optimal Method for FVIII:C and Anti-FVIII Quantification in a Patient Treated with Adynovi® who Developed Anti-FVIII during Treatment
-
Abstract Number: PB2169
Developing an ex vivo Method to Study Thrombosis in Cancer Patients: Cancer-associated Thrombosis-on-a-Chip
-
Abstract Number: PB2299
Developing Fluidic Models that Replicate Cephalic Arch Geometry and Flow Conditions of Dialysis Patients to Understand and Predict Access Thrombosis
-
Abstract Number: PB0122
Developing of a New Animal Artery Model of Atherothrombotic Stenosis using Perivascular Monopolar High-Frequency Electrical Current-Mediated Endothelial Injury Followed by a Cholesterol-Rich Diet Injury and Finally Perivascular Severe Cold Injury using Liquid Nitrogen
-
Abstract Number: PB2496
Development and External Validation of a Risk Assessment Model for First Venous Thromboembolism in Women Starting Combined Oral Contraceptives
-
Abstract Number: PB0350
Development and Performance Characterization of an Automated Chromogenic Assay for Human Factor IX Activity
-
Abstract Number: PB1871
Development and Validation of a Prediction Model (AHC) for Early Identification of Refractory Thrombotic Thrombocytopenic Purpura Using Nationally Representative Data
-
Abstract Number: PB0119
Development of a Clinical Cohort of HIV-infected Patients with Peripheral Vascular Disease
-
Abstract Number: PB0678
Development of a Flow Cytometry-based Assay for the Detection of ITP Autoantibodies
-
Abstract Number: PB0527
Development of a Logistic Regression Model for Prediction of Conversion Risk from Mild Cognitive Impairment (MCI) to Alzheimer´s Disease (AD)
-
Abstract Number: PB0468
Development of a Microfluidic Pillar Device to Study Hemostasis in vitro
-
Abstract Number: PB1966
Development of a Novel Mouse Model of Abdominal Aortic Aneurysm with Intraluminal Thrombus
-
Abstract Number: PB0497
Development of an Accessible Open Source Code in Python for High-Resolution Melting Data Analysis from Patients Diagnosed with Hemophilia A in Bogotá, Colombia
-
Abstract Number: PB2425
Development of Cyclic Peptide Inhibitors of Coagulation Factor XIa for Safer Anticoagulation
-
Abstract Number: PB2100
Development of Predictive Score for Venous Thromboembolism in Hematologic Malignancies
-
Abstract Number: PB2534
Deviations in Red Blood Cell Gas Transport Function in Pregnant State
-
Abstract Number: PB0030
Diabetes Mellitus and Risk of Intracranial Atherosclerosis: A Meta-Analysis Using Real-World Evidence
-
Abstract Number: PB2011
Diabetes Mellitus Increases Thrombin and Activated Protein C Effects on Mast Cell and Macrophages
-
Abstract Number: PB0507
Diagnosing and Categorizing Acquired Fibrinolysis Activity with Global Hemostatic Assays
-
Abstract Number: PB2267
Diagnosing Deep Vein Thrombosis in Patients with Suspected Symptoms and a Concurrent Malignancy: An Individual Participant Data Meta-Analysis
-
Abstract Number: PB0786
Diagnosis and Management of Acquired Von Willebrand Disease in Two Italian Centers
-
Abstract Number: PB0824
Diagnosis and Management of Acute Hemarthrosis and Haemophilic Arthropathy in Spain Using Unified Clinical and Ultrasound Criteria: Preliminary Results
-
Abstract Number: PB1590
Diagnosis and Management of von Willebrand Disease in a Portuguese Reference Center of Congenital Coagulopathies
-
Abstract Number: PB0362
Diagnosis and Treatment of Obstetrics Disseminated Intravascular Coagulation in Resource Limited Settings
-
Abstract Number: PB1437
Diagnosis of Inherited Platelet Disorders on a Blood Smear: The One-Year Experience of a Reference Laboratory
-
Abstract Number: PB1522
Diagnosis of von Willebrand Disease in Algeria Laboratory and Clinical phenotype: Single Center Experience
-
Abstract Number: PB1435
Diagnostic Approach to Inherited Thrombocytopenias in a Low-Income Setting
-
Abstract Number: PB0671
Diagnostic Performances Evaluation of LIAPHEN Free Protein S on CS-2500
-
Abstract Number: PB1589
Diagnostic Performances Evaluation of LIAPHEN vWF: Ag on CS-2500
-
Abstract Number: PB1664
Dietary Intake of Zinc Modulates Platelet Intracellular Levels and Haemostatic Parameters
-
Abstract Number: PB0330
Difference Molecular Profiles of Type 1 and 2 Inhibitor Developed in Mild/Moderate Hemophilia A
-
Abstract Number: PB/LB03
Differences in Outcomes between Real-World vs Clinical Trial in Atrial Fibrillation and Chronic Kidney Disease
-
Abstract Number: PB1003
Differences in Pharmacokinetic Evaluated by Clotting and Chromogenic Factor VIII Assays in Twelve Persons with Severe Hemophilia A on Prophylaxis with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc)
-
Abstract Number: PB0845
Differences in the Prediction of the Time above Target in Hemophilia A Patients Using a Chromogenic Assay and a One-stage Assay in Model-informed Precision Dosing
-
Abstract Number: PB2051
Differences in Treatment and Outcomes in Recently Diagnosed Atrial Fibrillation between the Netherlands and Belgium: Results from the GARFIELD-AF Registry
-
Abstract Number: PB0753
Different Incorporation of Apha2-plasmin Inhibitor C-terminal Forms into the Fibrin Clot
-
Abstract Number: PB2148
Differential Augmentation of Thrombin Generation by Andexanet Alfa in Lymphoma Patients
-
Abstract Number: PB1857
Differential Diagnosis of Thrombotic Thrombocytopenic Purpura at Acute Phase by the Ratio of VWF Activity to VWF Antigen Based on Automatic Immunologic Assays
-
Abstract Number: PB2062
Differential Effect of Direct Oral Anticoagulants (DOACs) on Thrombin Generation and Clot Lysis in Patients with Non Valvular Atrial Fibrillation (AF) and Venous Thromboembolism (VTE)
-
Abstract Number: PB0009
Differential Effects of Clopidogrel with or without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Placebo-Controlled Trial in Healthy Volunteers
-
Abstract Number: PB1939
Differential Expression of CD46 in Leukocytes by Flow Cytometry: Methodological Aspects
-
Abstract Number: PB1970
Differential Expression of Inflammatory Mediators in Venous Tissue and Serum Suggest Natural Killer (NK) Cell-mediated Responses in Chronic Venous Insufficiency
-
Abstract Number: PB2167
Differential Expression of Neutrophil Activation Markers in Venous Thromboembolism Patients with and without Association to Cancer
-
Abstract Number: PB1735
Differential Regulation of the Platelet GPIb-IX Complex by Anti-GPIbβ Antibodies
-
Abstract Number: PB0857
Differential Systemic Transcriptional Responses to Induced Joint Bleeding in Wild-type and Factor VIII-deficient Mice
-
Abstract Number: PB2376
Dilemma in Initiating Thromboprophylaxis in Critically Ill Patients
-
Abstract Number: PB0738
Dipicolinic Acid Produced by Fermentation (Bacillus subtilis natto)
-
Abstract Number: PB/CO01
Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients
-
Abstract Number: PB2398
Direct Oral anti-Xa Inhibitors for Treatment of Venous Thromboembolism after Gastrectomy: Report on 3 Cases
-
Abstract Number: PB2492
Direct Oral Anticoagulants and Antiepileptic Drugs: Is There Room for Concurrent Treatment?
-
Abstract Number: PB2414
Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Cerebral Vein Thrombosis
-
Abstract Number: PB1128
Direct Oral Anticoagulants Bleeding Events in Patients with Atrial Fibrillation Vs Venous Thromboembolism Admitted to an Emergency Department: Real-Life Study
-
Abstract Number: PB2465
Direct Oral Anticoagulants in Comparison with Vitamin K Antagonists and Antiplatelet Agents on Timing and Outcomes in Hip Fracture Surgery Patients Older than 75: The ORTHO-GER-DOAC Study
-
Abstract Number: PB2161
Direct Oral Anticoagulants in Patients with Hematological Malignancies
-
Abstract Number: PB2467
Direct Oral Anticoagulants in Patients with Severe Familial Thrombophilia
-
Abstract Number: PB1926
Direct Oral Anticoagulants versus Vitamin K Antagonists in Antiphospholipid Syndrome: A Meta-analysis
-
Abstract Number: PB2484
Direct Oral Anticoagulants vs. Warfarin for the Treatment of Venous Thromboembolism in Patients with Thrombophilia. A Single Center Experience
-
Abstract Number: PB1666
Direct Temporal Labelling of Platelets in vivo Allows Monitoring and Examination of Newly Formed and Aged Platelets to Reveal Changes in Receptor Expression Levels and Loss of Functional Ability
-
Abstract Number: PB/CO06
Disantangling the Mechanisms behind the Thrombotic Complications of COVID-19 Patients: Insights into Platelet and Endothelial Activation
-
Abstract Number: PB1402
Discontinuation of Chronic Low Dose Acetylsalicylic Acid Therapy Upon Intensive Care Medicine Department Admission Appears to Increase Mortality
-
Abstract Number: PB0208
Discordance Between the Neutralization Profile of Apixaban, Betrixaban, Edoxaban and Rivaroxaban in the Clotting Assays and Anti-Xa Measurements
-
Abstract Number: PB0835
Discrepancies between FVIII Assays in Routine Diagnosis and Treatment Monitoring of Haemophilia A
-
Abstract Number: PB0570
Discrepant Interpretation of HIT Screening Results on the Same Sample – Data from a UK NEQAS for Blood Coagulation Exercise
-
Abstract Number: PB0526
Discrimination between Acquired Hemophilia A and Lupus Anticoagulant Using Rotational Thromboelastometry (ROTEM)
-
Abstract Number: PB2547
Disorders in the Fibrinolytic System as a Possible Factor in the Failure of Assisted Reproductive Technologies
-
Abstract Number: PB1002
Dissecting the Paradox of “Severe” Hemophilia A (Clotting Factor VIII < 1%) with a Mild Clinical Phenotype in the Era of Prophylaxis
-
Abstract Number: PB0644
Distinguishing Patients Presenting Prolonged Activated Partial Thromboplastin Time with and without Bleeding Diathesis by Comparison of Immediate and post Incubation Mixing Test
-
Abstract Number: PB1028
Distribution of Hemophilia A and B within the INSIGHT Consortium
-
Abstract Number: PB0619
DOAC Intra-individual Variability in Patients with Non Valvular Atrial Fibrillation
-
Abstract Number: PB1719
DOAC Pharmacogenomics: Personalized Therapeutics to Avoid Bleeding and Thrombotic Complications
-
Abstract Number: PB0632
Doac-Remove Can Neutralize the Effect of Direct Oral Anticoagulants on Lupus Anticoagulant Assay: A Single-centre Experience
-
Abstract Number: PB2479
DOACs in Real Clinical Practice
-
Abstract Number: PB2181
Does blood Group Predicts Thrombosis Risk? A Pilot Study Assessing Thrombin Generation
-
Abstract Number: PB0551
Does Normal Diluted Russell Viper Venom Time Test Result Can Exclude Concentrations of Direct Oral Anticoagulants below 30 ng/mL?
-
Abstract Number: PB1910
Does the von Willebrand Factor: ADAMTS-13 Axis Differ between Antiphospholipid Syndrome and Systemic Lupus Erythematosus?
-
Abstract Number: PB0938
Does Variation between Label and Actual Potency of Factor VIII Concentrate Vials Affect Results of Pharmacokinetic (PK)-Guided Dosing of Replacement Therapy in Hemophilia A?
-
Abstract Number: PB0751
Down-regulation of Plasminogen Activator Inhibitor-1 (PAI-1) by in vivo Thrombin Generation and Subsequent Formation of Activated Protein C (APC) in Carriers of the Factor V Leiden (FVL) and Prothrombin 20210G>A Mutation (PTM)
-
Abstract Number: PB0745
Downregulation of the Procarboxypeptidase U (proCPU, TAFI, proCPB2) System in ApoE-/-Fbn1C1039G+/- Mice Is a Non-Lipid Related Pleiotropic Effect of Statin Therapy
-
Abstract Number: PB0651
DP-Filter, a Medical Device to Remove Edoxaban and Edoxaban-M4 from Plasma of Patients Taking Edoxaban
-
Abstract Number: PB0164
Drug Interactions in Edoxaban Treated Patients: A Pilot Study Revealing the Changes of the Metabolite to Parent Ratio and its Potential Clinical Importance
-
Abstract Number: PB2459
Drug-Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: A Systematic Review
-
Abstract Number: PB1478
Dual Antiplatelet Therapy in One Patient with a Immune GPVI Deficiency
-
Abstract Number: PB0933
Dynamic Changes in Peripheral Blood Transcriptome Profiles May Predict Inhibitor Formation in Previously Untreated Patients with Severe Hemophilia A
-
Abstract Number: PB2260
Dynamic Upper Limb Ultrasound in Idiopathic Upper Extremity Deep Vein Thrombosis
-
Abstract Number: PB2155
Dynamics of ADAMTS13 and vWF Activity Change in Ovarian Cancer Patients
-
Abstract Number: PB1753
Dysfunctional CLEC-2- and GPVI-mediated Signaling in Syk Y342F Knock-in Mouse Platelets
-
Abstract Number: PB1602
Dysfunctional RBM8A/Y14 Does Not Impair Megakaryopoiesis but Terminal Thrombopoiesis in Thrombocytopenia Absent Radii (TAR) Syndrome
-
Abstract Number: PB0461
Dyslipidaemia Associated with Increase of Thrombin Generation in Renal Transplant Recipients
-
Abstract Number: PB1480
Dysregulation of Platelet Serotonin and Platelet 14-3-3-Related Biomarkers in Sudden Infant Death Syndrome
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.